Viracta Therapeutics, Inc. (VIRX)
OTCMKTS
· Delayed Price · Currency is USD
0.0189
-0.0001 (-0.53%)
May 13, 2025, 1:16 PM EDT
Viracta Therapeutics Market Cap
Viracta Therapeutics has a market cap or net worth of $755.14 thousand as of May 13, 2025. Its market cap has decreased by -97.73% in one year.
Market Cap
755.14K
Enterprise Value
-3.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since February 25, 2021, Viracta Therapeutics's market cap has decreased from 8.68M to 755.14K, a decrease of -91.30%. That is a compound annual growth rate of -44.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 755.14K | -88.19% |
| Dec 31, 2024 | 6.39M | -70.95% |
| Dec 29, 2023 | 22.02M | -60.52% |
| Dec 30, 2022 | 55.77M | -59.05% |
| Dec 31, 2021 | 136.19M | 1,468.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 568.98M |
| CytoDyn | 497.14M |
| Glass House Brands | 478.11M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |